NEXUS Hip Stem
Microport Orthopedics, Inc. · Decision date Oct 1, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 1, 2026 for the NEXUS® Hip Stem, submitted by Microport Orthopedics, Inc. of Arlington, Tennessee, under 510(k) number K262473. The device falls under regulation 888.3353 with classification product code LZO and subsequent product code MEH, in the Orthopedic medical specialty and review panel. The application was received July 17, 2026, was not reviewed by a third party, and was not a combination product. A SESE decision is a 510(k) clearance, not a PMA approval.
The submission's stated purpose, per the October 1, 2026 FDA document, is to expand compatibility with previously 510(k) cleared NextStep Arthropedix femoral head components; the NEXUS stems are described as compatible with previously cleared MicroPort and NextStep Arthropedix femoral head and shell/liner components. The source does not specify which prior clearances are referenced, the testing or data relied upon, or any indications, patient-selection criteria or labeling language, so those details remain unknown here.
No predetermined change control plan was authorized, and no summary statement appears in the supplied data. Whether the expanded component compatibility carries clinical or legal implications beyond the cleared labeling cannot be determined from these records.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262473
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Microport Orthopedics, Inc.
- Product code
- LZO
- Decision code
- SESE
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented.
- Applicant
- Microport Orthopedics, Inc.
- Product code
- LZO
- FDA device class
- 2
FDA decision timeline
K262473 received
Application receipt date recorded by FDA.
K262473 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LZO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medacta International S.A. | 510(k) clearance | Sep 17, 2026 | FDA | |
| United Orthopedic Corporation | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Microport Orthopedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Arlington, TN
Sources and methodology
- Original FDA record: K262473
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
